Markets › India › NSE › AKUMS

Akums Drugs and Pharmaceuticals Ltd

NSE:AKUMSHealthcareNSE:NIFTY_MICROCAP250NSE:NIFTY_TOTAL_MKT

₹709.55−2.99%At closeAt close · Mon 19 Oct · ≈ AED 27.41 · Market cap $1.21B · Next earnings Thu 12 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	15.2%	34.8%	33.6%	35.8%	39.4%	21.5%	—	—
Operating margin	8.3%	8.8%	5.5%	9.0%	7.6%	8.4%	8.4%	+0.0 pts
Net margin	4.5%	−6.9%	2.7%	−0.1%	8.3%	5.9%	5.9%	+0.0 pts
EBITDA margin	10.9%	−2.3%	8.9%	3.2%	13.0%	14.5%	—	—
Return on equity	13.9%	−40.6%	13.2%	−0.6%	11.1%	7.7%	7.7%	−0.0 pts
Return on assets	5.7%	−8.2%	2.9%	−0.1%	8.2%	4.7%	4.7%	+0.0 pts
Return on capital employed	14.2%	17.9%	9.6%	15.6%	9.6%	8.4%	—	—
Debt / equity	0.1×	0.6×	0.9×	0.8×	0.0×	0.0×	0.0×	−0.5%
Debt / assets	6.0%	12.9%	19.0%	16.1%	2.1%	2.9%	—	—
Interest coverage	39.1×	19.7×	4.2×	7.2×	10.2×	3.9×	—	—
Current ratio	2.0×	1.5×	1.5×	1.6×	2.5×	3.3×	3.3×	+0.0%
Quick ratio	1.3×	0.9×	0.9×	1.1×	1.8×	2.6×	—	—
Cash ratio	0.0×	0.0×	0.0×	0.1×	0.1×	0.4×	0.4×	+0.0%
Asset turnover	1.3×	1.2×	1.1×	1.1×	1.0×	0.8×	—	—
Inventory turnover	5.4×	3.3×	3.2×	4.1×	3.6×	4.5×	—	—
Receivables turnover	5.0×	4.1×	4.1×	4.8×	5.2×	5.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.